Table 35 (abstract P335). See text for description
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two
JIA sub-group | Frequency | Sex (male/female) | Age at diagnosis (years) | Diagnosis delay (months) | Active /Remission |
|---|---|---|---|---|---|
Oligo-JIA (extended) | 6 (2,3%) | 3/3 | 5,9 | 5 | 3/3 |
Oligo-JIA (persistent) | 81 (30,6%) | 27/54 | 7,6 | 5,3 | 18/63 |
RF (+) Poly-JIA | 10 (3,8%) | 4/6 | 12,1 | 11,5 | 8/2 |
RF (-) Poly-JIA | 36 (13,5%) | 13/23 | 9,5 | 9,6 | 18/18 |
Enthesitis related arthritis (ERA) | 87 (32,8%) | 68/19 | 13,2 | 8,7 | 27/60 |
Psoriatic arthritis | 5 (1,9%) | 2/3 | 6,6 | 5,2 | 2/3 |
Systemic JIA (sJIA) | 35 (13,2%) | 15/20 | 8,1 | 1,2 | 4/31 |
Undifferentiated | 5 (1,9%) | 4/1 | 10,8 | 8 | 2/3 |
Total | 265 | 136/129 | 9.9 | 6,7 | 82/183 |